Biomea Fusion, Inc. (BMEA) vs Rallybio Corporation (RLYB)

A side-by-side comparison of Biomea Fusion, Inc. and Rallybio Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BMEA vs RLYB

growth of $100 · dividends reinvested · last 5y
BMEA -90.2% (-37.1%/yr)RLYB -85.0% (-31.6%/yr)RLYB compounded faster over this window
0100200300Start $10020222023202420252026$10$15
BMEA RLYB

BMEA vs RLYB: by the numbers

  • •BMEA is the larger company ($91M vs $91M market cap).
  • •RLYB is profitable (7051.24% net margin) while BMEA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricBMEARLYB
P/E ratioN/A2.19
P/S ratioN/A140.43
P/B ratio7.510.96
FCF yieldN/A29.04%

Profitability

MetricBMEARLYB
Gross margin0.00%89.28%
Operating margin0.00%-3270.86%
Net margin0.00%7051.24%
ROE-268.09%48.20%
ROIC-220.02%-24.40%

Growth (annualized)

MetricBMEARLYB
Total return CAGR (5Y)-36.56%-35.80%

Frequently asked

Is BMEA or RLYB more profitable?
RLYB runs the higher net margin — BMEA at 0.00% versus RLYB at 7051.24%.
How have BMEA and RLYB total returns compared?
Over the past 5 years, BMEA delivered -36.56% and RLYB delivered -35.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.